Search results for " Langerhans cell"

showing 6 items of 6 documents

Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis.

2008

:  We present the case of a woman with diabetes insipidus with subsequent genital and multiorgan Langerhans cell histiocytosis (LCH). A monolateral and slightly infiltrated erythematous plaque of the vulva was observed. Hematoxylin and eosin and immunophenotypic studies were performed. The primary antibodies used were monoclonal antibody to S100, CD1a, CD34, HLA-DR, PCNA, CD45Ro, CD40, and langerin. The histology of the infiltrates revealed a granulomatous reaction pattern, with extensive aggregates of histiocyte proliferation. The histiocytes, morphologically characterized by a pale staining of cytoplasm surrounding a grooved reniform nucleus, sometimes contained small distinct nucleoli. L…

AdultPathologymedicine.medical_specialtyCell typeLangerhans cellLangerinDermatologyVinblastineMethylprednisoloneImmunophenotypingVulvaLangerhans cell histiocytosisErythematous plaqueSettore MED/35 - Malattie Cutanee E VenereemedicineHumansHistiocyteCD40integumentary systembiologyHistiocytesGeneral Medicinemedicine.diseaseImmunohistochemistryHistiocytosis Langerhans-Cellmedicine.anatomical_structureTreatment Outcomevulvar Langerhans cell histiocytosisGiant cellErythemaLangerhans Cellsbiology.proteinDrug Therapy CombinationFemaleDiabetes InsipidusDermatologic therapy
researchProduct

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification

2007

Multisystem Langerhans cell histiocytosis (MS-LCH) is associated with high mortality when patients have risk organ involvement (RO+) or are younger than 2 years. In an international randomized trial, LCH-II, we intensified their treatment: arm A consisted of 6 weeks of daily prednisone and weekly vinblastine followed by 18 weeks of daily 6-mercaptopurine with vinblastine/prednisone pulses; etoposide was added in arm B. Considering all 193 randomized risk patients, there were similar outcomes: rapid (6 weeks) response (arm A vs arm B: 63%/71%), 5-year survival probability (74%/79%), disease reactivation frequency (46%/46%), and permanent consequences (43%/37%). However, (1) patients younger …

Malemedicine.medical_specialtyImmunologyAdult Langerhans Cell HistiocytosisBiochemistryGastroenterologylaw.inventionLangerhans cell histiocytosisRandomized controlled trialRisk FactorsPrednisonelawInternal medicineHumansMedicineEtoposideDemographyHematologybusiness.industryInfantCell BiologyHematologymedicine.diseaseSurgeryVinblastineSurvival RateHistiocytosis Langerhans-CellTreatment OutcomeChild PreschoolOrgan involvementFemalebusinessmedicine.drugBlood
researchProduct

INTERNATIONAL JOURNAL OF CLINICAL DENTISTRY

2018

Diagnosis and Management of Oral Langerhans Cell Histiocytosis Emanoele Paixão da Silva Silva, Carina Myung Rodenbeck, Monira Samáan Kallas, Cássia Maria Fischer Rubira, and Paulo Sérgio da Silva Santos Mandibular-Infected Buccal Cyst: Unique Radiographic Appearance Gustavo Zanna Ferreira, Cássia Maria Fischer Rubira, Letícia Rodrigues Nery, Alberto Consolaro, Izabel Regina Fischer Rubira-Bullen, and Paulo Sérgio da Silva Santos PRF - The Magical Resort in Surgical Dentistry Archana Mootha, Julie Toby Thomas, Sankari Malaiappan, Sheeja S. Varghese, and N. D. Jayakumar Endodontic Management of a Macrodont: A Rare Tooth Anomaly Rahul Rathi and Priti Saroha Maxillary Canine Root Resorption Con…

Oral Langerhans Cell HistiocytosisBuccal CystSurgical DentistryMacrodontRoot ResorptionTooth DiscolorationAntifungal AgentGuided Bone RegenerationDentin Dysplasia Type IILinear Measurement in Dental Implant SiteENDODONTIC BIOFILM
researchProduct

A rare case of solitary brain Langerhans cell histiocytosis with intratumoral hemorrhage in a patient affected by Turner syndrome

2016

Background: Langerhans cell histiocytosis (LCH) is a rare disease involving clonal proliferation of cells with characteristics similar to bone marrow-derived Langerhans cells. The case of a young woman, affected by Turner syndrome and a solitary intraparenchymal LCH associated with an osteolytic lesion of the overlying skull, is presented. Case Description: The patient, with an insidious history of headache and a growing soft mass in the left frontal region, presented with a sudden generalized tonic-clonic epileptic seizure. Neuroradiological investigations showed an osteolytic lesion of the left frontal bone and an underlying brain lesion associated with recent signs of bleeding. The patie…

Pathologymedicine.medical_specialtyCase ReportHemorrhageHemorrhage Langerhans cell histiocytosis skull neoplasm03 medical and health sciences0302 clinical medicineLangerhans cell histiocytosisTurner syndromeRare caseMedicineskull neoplasmbusiness.industryPatient affectedLangerhans cell histiocytosiLangerhans cell histiocytosisSkull Neoplasmmedicine.diseaseHemorrhage; Langerhans cell histiocytosis; skull neoplasmOsteolytic lesionSkullmedicine.anatomical_structure030220 oncology & carcinogenesisSurgeryNeurology (clinical)business030217 neurology & neurosurgeryRare diseaseSurgical Neurology International
researchProduct

Eosinophilic granuloma of the skull vault: A case report

2016

Background: Eosinophilic granuloma is the benign form of Langerhans cell histiocytosis, a rare proliferative disorder. Skull osteolytic lesions are quite frequently encountered. Case report: We report the case of a 16 year old boy who was admitted to our Department with a painful swelling left frontal mass. A diagnosis of eosinophilic granuloma was presumed on the basis of the neuroradiological findings. Surgical removal of the lesion was achieved and the bone defect reconstructed by autologous fibrin glue and a titanium mesh. Histopathology confirmed the diagnosis. Conclusion: Although uncommon, eosinophilic granuloma should be considered in the differential diagnosis in case of an osteoly…

Settore MED/27 - NeurochirurgiaCalvarial bone Eosinophilic granuloma Langerhans cell
researchProduct

A rare case of oral multisystem Langerhans cell histiocytosis

2017

Langerhans cell histiocytosis (LCH) is a rare disorder characterized by high proliferation of Langerhans dendritic cells. LCH is a solitary or multifocal disease that primarily involves bone tissue and often affects children and young men. A 29 years-old Caucasian man was referred to the Oral Surgery Unit of George Eastman Hospital - Umberto I teaching hospital, with third degree mobility of teeth belonging to second, third and fourth quadrant. Panoramic radiograph showed multiple radiolucent areas with well demarcated borders on the right and left site of the mandible and on the left site of the maxilla. Extractions of compromised teeth and biopsy of the osteolytic tissue were performed. T…

medicine.medical_specialtyPanoramic radiographDifferential diagnosis; Langerhans cell histiocytosis; Microscopic diagnosis; Dentistry (all)Case ReportSettore MED/28 - MALATTIE ODONTOSTOMATOLOGICHE03 medical and health sciencesQuadrant (abdomen)0302 clinical medicineLangerhans cell histiocytosisRare caseBiopsymedicineGeneral DentistryOral Medicine and Pathologymedicine.diagnostic_testbusiness.industrySoft tissueLangerhans cell histiocytosis030206 dentistryMicroscopic diagnosismedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologySurgery030220 oncology & carcinogenesisMaxillaUNESCO::CIENCIAS MÉDICASDentistry (all)Proper treatmentDifferential diagnosisbusiness
researchProduct